Skip to main content
Equibles
GDRX logo

GDRX · GoodRx Holdings, Inc.

Track GDRX — free

Use GDRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GDRX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.73 +0.01 (+0.27%) At close · Aug 14
Market Cap
$1.27B
Shares
341.15M

GoodRx Holdings, Inc. Earnings Call Transcripts

Every quarterly earnings call for GoodRx Holdings, Inc. (GDRX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼4% $187.32M −$41.73M '22 Q3 22-11-08 ▼13.7% $184.11M −$1.97M '22 Q4 23-02-28 ▼9.5% $183.99M −$3.29M '23 Q1 23-04-25 ▼1.1% $189.68M $58.79M '23 Q2 23-08-09 ▼3.9% $179.96M −$38.49M '23 Q3 23-11-09 ▲6.8% $196.64M −$25.87M '23 Q4 24-02-29 ▲7.6% $197.88M −$1.01M '24 Q1 24-05-09 ▲5.8% $200.61M $6.69M '24 Q2 24-08-08 ▲8.5% $195.25M $3.96M '24 Q3 24-11-07 ▲1% $198.58M $6.74M '24 Q4 25-02-27 ▲2.6% $202.97M $11.05M '25 Q1 25-05-07 ▲1.2% $203.07M $12.84M '25 Q2 25-08-06 ▲0.4% $196.03M $1.12M '25 Q3 25-11-04 ▼1.9% $194.78M $5.42M '25 Q4 26-02-25 ▼4.4% $194.01M $1.17M '26 Q1 26-05-06 LATEST ▼1.3% $200.41M $8.54M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
GoodRx Holdings, Inc. Q2 FY2026 Earnings Call
Revenue
$200.41M
▼ 1.3% YoY
Diluted EPS
$0.02
▼ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
GoodRx Holdings, Inc. Q1 FY2026 Earnings Call
Positive tone TrumpRx integration and incremental volume Subscription and weight loss offering PharmaDirect growth and scale
Revenue
$194.01M
▼ 4.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
GoodRx Holdings, Inc. Q4 FY2025 Earnings Call
Confident tone Pharma Manufacturer Solutions / Pharma Direct Consumer Reach and Engagement TrumpRx Partnership
Revenue
$194.78M*
▼ 1.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
GoodRx Holdings, Inc. Q3 FY2025 Earnings Call
Positive tone Pharma Manufacturer Solutions growth Policy environment / TrumpRx & MFN Kroger RxSmartSaver / retail partnerships
Revenue
$196.03M
▲ 0.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
GoodRx Holdings, Inc. Q2 FY2025 Earnings Call
Positive tone Integrated Savings Program (ISP) headwinds Pharma manufacturer solutions growth Retail and prescription marketplace partnerships
Revenue
$203.07M
▲ 1.2% YoY
Diluted EPS
$0.04
▲ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
GoodRx Holdings, Inc. Q1 FY2025 Earnings Call
Positive tone Prescription marketplace and pharmacy partnerships Rite Aid bankruptcy Pharma Manufacturer Solutions and GLP-1 opportunity
Revenue
$202.97M
▲ 2.6% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
GoodRx Holdings, Inc. Q4 FY2024 Earnings Call
Confident tone Healthcare professional workflow tools and technology Integrated Savings Program (ISP) and direct contracting GLP-1 supply, demand, and pricing opportunity
Revenue
$198.58M*
▲ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
GoodRx Holdings, Inc. Q3 FY2024 Earnings Call
Positive tone Integrated Savings Program (ISP) Pharma manufacturer solutions / brand growth Adjusted EBITDA performance
Revenue
$195.25M
▲ 8.5% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
GoodRx Holdings, Inc. Q2 FY2024 Earnings Call
Cautious tone Retail pharmacy store closures Integrated Savings Program (ISP) Pharma manufacturer solutions
Revenue
$200.61M
▲ 5.8% YoY
Diluted EPS
$0.02
▼ 85.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
GoodRx Holdings, Inc. Q1 FY2024 Earnings Call
Positive tone Integrated Savings Program (ISP) Pharma Manufacturer Solutions Retail direct contracting shift
Revenue
$197.88M
▲ 7.6% YoY
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
GoodRx Holdings, Inc. Q4 FY2023 Earnings Call
Positive tone Retail pharmacy partnerships / hybrid model Integrated savings program (ISP) for commercial plans 2024 financial outlook
Revenue
$196.64M*
▲ 6.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GoodRx Holdings, Inc. Q3 FY2023 Earnings Call
Revenue
$179.96M
▼ 3.9% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
GoodRx Holdings, Inc. Q2 FY2023 Earnings Call
Revenue
$189.68M
▼ 1.1% YoY
Diluted EPS
$0.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GoodRx Holdings, Inc. Q1 FY2023 Earnings Call
Revenue
$183.99M
▼ 9.5% YoY
Diluted EPS
$-0.01
▼ 133.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
GoodRx Holdings, Inc. Q4 FY2022 Earnings Call
Revenue
$184.11M*
▼ 13.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
GoodRx Holdings, Inc. Q3 FY2022 Earnings Call
Revenue
$187.32M
▼ 4% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
GoodRx Holdings, Inc. Q2 FY2022 Earnings Call
Revenue
$191.80M
▲ 8.6% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
GoodRx Holdings, Inc. Q1 FY2022 Earnings Call
Revenue
$203.33M
▲ 26.7% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
GoodRx Holdings, Inc. Q4 FY2021 Earnings Call
Revenue
$213.26M*
▲ 38.9% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
GoodRx Holdings, Inc. Q3 FY2021 Earnings Call
Revenue
$195.10M
▲ 38.9% YoY
Diluted EPS
$-0.04
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
GoodRx Holdings, Inc. Q2 FY2021 Earnings Call
Revenue
$176.63M
▲ 43.3% YoY
Diluted EPS
$0.07
▼ 12.5% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
GoodRx Holdings, Inc. Q1 FY2021 Earnings Call
Revenue
$160.43M
▲ 20.3% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
GoodRx Holdings, Inc. Q4 FY2020 Earnings Call
Revenue
$153.54M*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
GoodRx Holdings, Inc. Q3 FY2020 Earnings Call
Revenue
$140.45M
▲ 38% YoY
Diluted EPS
$-0.21
▼ 520% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 1809519 CUSIP 38246G108 13F (30d) 161 filings 158 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)